Virtu KCG Holdings’s Fibrocell Science Inc. FCSC Stock Holding History

Virtu KCG Holdings’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$87K	Buy	+4,314	New	+$53.2K	﹤0.01%	2456
2017 Q1	–	Sell	-4,206	Closed	-$40K	–	4019
2016 Q4	$40K	Buy	4,206 +3,505	+500%	+$37.6K	﹤0.01%	3138
2016 Q3	$8K	Buy	+701	New	+$10.4K	﹤0.01%	2989
2016 Q1	–	Sell	-756	Closed	-$52K	–	3978
2015 Q4	$52K	Sell	756 -733	-49%	-$52.7K	﹤0.01%	3153
2015 Q3	$86K	Buy	1,489 +79	+6%	+$6.99K	﹤0.01%	2874
2015 Q2	$111K	Buy	+1,410	New	+$94.9K	﹤0.01%	2869
2013 Q4	–	Sell	-806	Closed	-$53K	–	4413
2013 Q3	$53K	Buy	+806	New	+$65.1K	﹤0.01%	3500

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu KCG Holdings's FCSC Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Fibrocell Science Inc. (FCSC) in Q2 2017: 4,314 shares worth $87K. The stake represents ﹤0.01% of the portfolio and ranks #2456 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in FCSC as recently as Q4 2016.

Virtu KCG Holdings first reported a position in FCSC in Q3 2013 and has held it in 7 quarters since. The position peaked at $111K in Q2 2015. 29 funds tracked by Wall St. Rank hold FCSC as of Q2 2017.

Virtu KCG Holdings held 4,314 shares of Fibrocell Science Inc. worth $87K as of Q2 2017.
Fibrocell Science Inc. was a new Virtu KCG Holdings position in Q2 2017.
Fibrocell Science Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2456 holding.
Virtu KCG Holdings first reported a position in Fibrocell Science Inc. in Q3 2013 and has held it in 7 quarters since.
Virtu KCG Holdings's Fibrocell Science Inc. position peaked at $111K in Q2 2015.
29 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.